GlassScriptPhysician profile
Curtis B Wagner
NPI 1972615037
$5,461.17
in general payments reported to CMS, 2019-2025
31 companies · $290 in 2025
The $290 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $648 · 2020: $350 · 2021: $3,396 · 2022: $349 · 2023: $253 · 2024: $174 · 2025: $290.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $718.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $717.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $2,944.08 | 2021 | |
| Stryker Corporation | $521.98 | 2019-2024 | Citrefix, 7 X 23mm Citrelock Implant, Prophecy |
| Horizon Therapeutics Plc | $473.08 | 2019-2022 | |
| Smith+Nephew, INC. | $306.13 | 2019-2025 | Collagenase Santyl |
| Curonix LLC | $162.57 | 2023-2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Paragon 28, INC. | $115.47 | 2019 | |
| Paratek Pharmaceuticals, INC. | $113.27 | 2021-2025 | Nuzyra |
| Dynasplint Systems INC. | $102.64 | 2021 | |
| Organogenesis INC. | $78.87 | 2022-2025 | Puraply Wound Matrix |
| Globus Medical, INC. | $64.92 | 2025 | Senza |
| Wright Medical Technology, INC. | $51.02 | 2019 | |
| Grt US Holding, INC. | $46.65 | 2020-2022 | |
| Zimvie INC. | $42.14 | 2022 | |
| Sebela Pharmaceuticals INC. | $41.50 | 2021-2022 | |
| Nabriva Therapeutics, Plc | $39.65 | 2021 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zyla Life Sciences, INC. | $38.98 | 2019 | |
| Medtronic, INC. | $38.40 | 2023-2025 | Intellis Adaptivestim |
| Integra Lifesciences Corporation | $35.14 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $28.35 | 2025 | |
| Ermi LLC | $26.33 | 2019-2021 | |
| Averitas Pharma INC. | $24.03 | 2023 | Qutenza |
| Surgenex LLC | $22.30 | 2025 | Renograft, Surmatrix, Ardeograft |
| Embody, INC. | $21.42 | 2021 | |
| Aroa Biosurgery Incorporated | $19.96 | 2022 | |
| Reprise Biomedical, INC. | $19.07 | 2025 | Miro3d |
| Kerecis Limited | $18.74 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Pacira Pharmaceuticals Incorporated | $16.46 | 2019 | |
| Access Pro Medical, LLC | $15.28 | 2025 | Matriderm |
| Cashflow Solutions, LLC | $14.00 | 2024 | Lympha Press Optimal Plus(US) Bt, Pcd-51 731a (US) - White, Pcd-52 737a (US) White |
| Bioventus LLC | $13.26 | 2022 | |
| Heron Therapeutics, INC. | $5.48 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Curtis Wagner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.